- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Sucampo Pharmaceuticals Inc+ Add to Watchlist
SCMP:US18.0600 USD 0.5100 2.91%
As of 20:10:00 ET on 05/06/2015.
Company Profile for Sucampo Pharmaceuticals Inc (SCMP)
Sucampo Pharmaceuticals, Inc. researches and develops drugs based on protones, which are derived from functional fatty acids. The Company produces a prescription drug for the treatment of chronic idiopathic constipation.
Sucampo Pharmaceuticals Inc
Key Executives for Sucampo Pharmaceuticals Inc (SCMP)
|Peter GreenleafChief Executive Officer||Andrew P SmithChief Financial Officer|
|Peter A KienerChief Scientific Officer||Thomas J KnappExec VP/Chief Legal Ofcr/Secy|
|Matthias AlderExec VP:Bus Dev & Licensing||Silvia TaylorSenior VP:Investor Relations|
|Steven CaffeSenior VP:Regulatory Affairs||Stanley G MieleSenior VP:Sales & Marketing|
|Kathryn De Santis "Kate"VP:Investor Relations|